Inventor · disambiguated record

David C. Henke

Also filed as: HENKE DAVID C

9 granted patents·1 pending application·346 citations·filing 1993–2024

92Inventor score

Technology areasA61P A01N A61K

Files withMOLICHEM MEDICINES INC4 UNIV NORTH CAROLINA CHAPEL HILL4 BURROUGHS WELLCOME CO1 UNIV NORTH CAROLINA1

Top patents by PatentIndex Score

10 records

0196US11058743B2Methods and compositions for treating mucosal tissue disordersUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Jul 13, 2021·12 cites·24 claims
0294US9308234B2Methods and compositions for treating mucosal tissue disordersUNIV NORTH CAROLINA·Filed 2014·Granted Apr 12, 2016·22 cites·26 claims
0393US10406200B2Methods and compositions for treating mucusal tissue disordersUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Sep 10, 2019·12 cites·18 claims
0493US5849706AMethod of treating retained asthma pulmonary secretionsMOLICHEM MEDICINES INC·Filed 1998·Granted Dec 15, 1998·87 cites·3 claims
0590US11938166B2Methods and compositions for treating mucosal tissue disordersUNIV NORTH CAROLINA CHAPEL HILL·Filed 2021·Granted Mar 26, 2024·1 cites·36 claims
0690US5512269AMethod of treating retained pulmonary secretionsBURROUGHS WELLCOME CO·Filed 1993·Granted Apr 30, 1996·63 cites·27 claims
0787US5683675AMethod of treating retained pulmonary secretionsMOLICHEM MEDICINES INC·Filed 1995·Granted Nov 4, 1997·57 cites·7 claims
0886US5716931AMethod of treating retained pulmonary secretionsMOLICHEM MEDICINES INC·Filed 1995·Granted Feb 10, 1998·51 cites·8 claims
0985US2025018003A1Methods and compositions for treating mucosal tissue disordersUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
1082US5651957AMethod of treating retained pulmonary secretionsMOLICHEM MEDICINES INC·Filed 1995·Granted Jul 29, 1997·41 cites·2 claims

Join the waitlist — get patent alerts

Get an alert when David C. Henke files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →